SCHEMBL9162850

SCHEMBL9162850

Cc1nn(-c2ccccc2)c(C(=O)O)c1OC(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.47
MDM2 Q00987 1/20 0.47
MCL1 Q07820 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
GAA P10253 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 4/20 0.44
MAPT P10636 3/20 0.44
POLB P06746 3/20 0.44
RAB9A P51151 3/20 0.44
NPSR1 Q6W5P4 2/20 0.44
PDE4D Q08499 1/20 0.44
TP53 P04637 1/20 0.43
KDM4E B2RXH2 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
APEX1 P27695 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NPC1 O15118 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9162542 0.88 HPGD (0.53) BCL2MDM2MCL1ALDH1A1HPGD
SCHEMBL9165974 0.75 MAPT (0.37) GAAALDH1A1MAPTPOLBTP53
SCHEMBL11789395 0.74 CYP1A2 (0.53) CYP1A2CYP2C9CYP2C19ALDH1A1HPGD
SCHEMBL9166485 0.74 ALDH1A1 (0.35) ALDH1A1MAPTTP53KDM4E
SCHEMBL9157928 0.72 SMN1; SMN2 (0.37) CYP1A2CYP2C9CYP2C19GAAMAPT
SCHEMBL3387691 0.71 SMN1; SMN2 (0.56) BCL2MDM2MCL1CYP1A2CYP2C9
SCHEMBL3265133 0.69 NPSR1 (0.45) BCL2MDM2MCL1CYP1A2CYP2C19
SCHEMBL3262218 0.69 NPSR1 (0.49) BCL2MDM2MCL1CYP1A2CYP2C19
SCHEMBL10756621 0.69 PPARG (0.53) ALDH1A1KDM4E
SCHEMBL9826688 0.69 BCL2 (0.36) BCL2MDM2MCL1GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5442060-A Treating hyperlipemia, atherosclerosis MITSUBISHI KASEI CORPORATION (JP) 1995-08-15 US disclosed
EP-0591830-A1 Carboxamide and urea derivatives having ACAT-inhibiting activityM Mitsubishi Chemical Corporation (JP) 1994-04-13 EP disclosed